Medicare Enrolled

Dr. David Greenwald, MD

Hematology & Oncology · Kingston, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
382 PIERCE ST, Kingston, PA 18704
5702887231
Registered in NPPES since 2006
NPI: 1558380295 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Greenwald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greenwald? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Greenwald

Dr. David Greenwald is a hematology & oncology specialist in Kingston, PA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Greenwald performed 361,018 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Greenwald received a total of $2,937 from 43 pharmaceutical and/or device companies across 159 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Greenwald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 0% volume in PA $2,937 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
361,018
Medicare services
Top 0% in PA for hematology & oncology
Not available
Unique patients (not deduplicated)
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Injectafer)
An intravenous injection of ferric carboxymaltose, an iron replacement medication.
227,250 $1 $5
Nivolumab injection (Opdivo) 24,580 $24 $51
Denosumab injection (Prolia/Xgeva) 24,300 $18 $55
Pembrolizumab injection (Keytruda) 17,400 $43 $76
Oxaliplatin chemotherapy injection
This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg.
17,194 $0 $5
Paclitaxel chemotherapy injection 11,000 $0 $7
Darbepoetin injection (Aranesp) for anemia
An injection of darbepoetin alfa used for non-end-stage renal disease purposes.
5,132 $2 $8
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
4,935 $0 $8
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
3,722 $8 $40
Bevacizumab biosimilar injection, 10 mg
An injection of bevacizumab-awwb, a biosimilar medication, administered in a 10 mg dose.
3,570 $23 $100
Anti-nausea injection (Aloxi/palonosetron) 3,021 $1 $55
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
2,541 $10 $37
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,841 $92 $250
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
1,768 $8 $12
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
999 $96 $635
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
794 $61 $150
Injection, leucovorin calcium, per 50 mg 700 $3 $25
Injection, potassium chloride, per 2 meq 700 $0 $2
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
669 $22 $151
Carboplatin chemotherapy injection, 50 mg
Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection.
624 $2 $225
Office visit for established patient
An office visit for an existing patient that may not require the healthcare professional to be present.
599 $17 $75
Lactate dehydrogenase (LDH) level test
A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease.
561 $6 $22
Iron level test 546 $6 $30
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
546 $8 $30
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
470 $10 $100
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg 406 $3 $180
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
396 $47 $325
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
335 $12 $125
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
314 $1 $15
Additional hour of intravenous hydration
This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy.
304 $10 $100
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
302 $1 $2
Direct bilirubin level test
A blood test that measures the amount of direct bilirubin in your body. Direct bilirubin is the form of the waste product processed by the liver.
272 $5 $18
Intravenous infusion of new drug or substance, 1 hour or less
This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less.
272 $48 $250
Vitamin B-12 injection
An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg.
248 $1 $10
Leuprolide acetate (for depot suspension), 7.5 mg 246 $132 $646
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
244 $21 $175
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
228 $52 $275
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
219 $40 $125
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
179 $24 $177
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
165 $62 $169
Magnesium sulfate injection, per 500 mg
An injection of magnesium sulfate administered in 500 mg increments.
158 $1 $2
Magnesium level test
A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess.
152 $7 $24
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
127 $1 $40
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
104 $29 $35
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
85 $80 $250
Irrigation of implanted venous access device
This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids.
81 $17 $85
Flu vaccine, quadrivalent
A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection.
75 $75 $99
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
75 $117 $350
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
71 $102 $331
Intravenous push injection of new drug or substance
A healthcare provider injects a new medication or substance directly into a vein using a push technique.
64 $41 $250
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
64 $5 $300
Normal saline infusion, 500 ml
Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution.
52 $1 $17
Basic metabolic blood panel
A blood test that measures a group of basic chemicals, including total calcium levels.
42 $8 $30
Prolonged intravenous chemotherapy administration
This procedure involves the administration of chemotherapy medication directly into a vein over an extended period.
41 $97 $375
5% dextrose/water (500 ml = 1 unit) 34 $1 $16
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
32 $5 $18
Blood urea nitrogen test
A blood test that measures the amount of urea nitrogen to assess kidney function.
32 $4 $14
Influenza vaccine, quadrivalent, 0.5 ml dosage 30 $20 $50
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
26 $135 $438
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
25 $4 $16
Phosphate level test
A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong.
23 $5 $17
Normal saline infusion, 1000 cc
Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution.
22 $2 $20
Stool test for blood
A laboratory test that checks a stool sample for hidden blood using a chemical reaction. This test helps detect bleeding in the digestive tract.
11 $4 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
63.7% high complexity
32.1% medium
4.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,937
Total received (2018-2024)
Avg $420/year across 7 years
Top 44% in PA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
159
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$595
2023
$640
2022
$629
2021
$278
2020
$178
2019
$417
2018
$199

Payments by company (2024)

PFIZER INC.
$141
Novartis Pharmaceuticals Corporation
$136
Celgene Corporation
$91
ARRAY BIOPHARMA INC
$47
ABBVIE INC.
$41
Merck Sharp & Dohme LLC
$31
SHIELD THERAPEUTICS INC
$29
Daiichi Sankyo Inc.
$23
GlaxoSmithKline, LLC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$19
GENZYME CORPORATION
$15
Top 3 companies account for 61.8% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$382
PFIZER INC.
$301
Genentech USA, Inc.
$244
Astellas Pharma US Inc
$176
Pharmacyclics LLC, An AbbVie Company
$171
Celgene Corporation
$157
Intuitive Surgical, Inc.
$128
ARRAY BIOPHARMA INC
$100
Kite Pharma, Inc.
$93
Merck Sharp & Dohme LLC
$90
Alexion Pharmaceuticals, Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$71
Daiichi Sankyo Inc.
$70
Amgen Inc.
$68
AstraZeneca Pharmaceuticals LP
$66
ABBVIE INC.
$65
GENZYME CORPORATION
$61
Gilead Sciences, Inc.
$52
GlaxoSmithKline, LLC.
$42
JAZZ PHARMACEUTICALS INC.
$37
Seagen Inc.
$37
Lilly USA, LLC
$35
E.R. Squibb & Sons, L.L.C.
$34
Pharmacyclics LLC, an AbbVie Company
$30
Foundation Medicine, Inc.
$29
SHIELD THERAPEUTICS INC
$29
BeiGene USA, Inc.
$23
Merck Sharp & Dohme Corporation
$22
Stemline Therapeutics Inc.
$21
Organon LLC
$20
Janssen Biotech, Inc.
$19
Ipsen Biopharmaceuticals, Inc
$19
Bayer Healthcare Pharmaceuticals Inc.
$19
EISAI INC.
$18
Mylan Institutional Inc.
$17
Seattle Genetics, Inc.
$17
Myovant Sciences Inc.
$17
Apellis Pharmaceuticals, Inc.
$16
AVEO Pharmaceuticals, Inc.
$16
Dova Pharmaceuticals
$14
Taiho Oncology, Inc.
$14
Progenics Pharmaceuticals, Inc.
$14
Heron Therapeutics, Inc.
$13
Top 3 companies account for 31.5% of all-time payments
Associated products mentioned in payments ›
ABECMA · ACCRUFER · ADCETRIS · Alecensa · Aliqopa · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · CABLIVI · CALQUENCE · CYRAMZA · Columvi · Da Vinci Surgical System · Doptelet · ELIQUIS · ENJAYMO · EPKINLY · Empaveli · Erleada · FOTIVDA · FOUNDATIONONE · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · Imbruvica · KANJINTI · KEYTRUDA · KISQALI · Kadcyla · Kyprolis · LIBTAYO · LORBRENA · LUPRON DEPOT · LUTATHERA · Lenvima · Lonsurf · MEKINIST · Nplate · Nubeqa · OJJAARA · ONTRUZANT · ORGOVYX · Orserdu · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PYLARIFY · Padcev · Perjeta · Pomalyst · REBLOZYL · RETEVMO · SCEMBLIX · SOLIRIS · Somatuline Depot · Sustol · TAGRISSO · Trodelvy · VENCLEXTA · Venclexta · XTANDI · Xtandi · Yescarta · ZEPZELCA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a hematology & oncology specialist in Kingston?
Compare hematology & oncology specialists in the Kingston area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists in nearby ZIP areas
18
County median income
$62,321
Nearest hospital to ZIP centroid (approximate)
GEISINGER BEHAVIORAL HEALTH CENTER NORTHEAST
12.5 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Greenwald is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Greenwald experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Greenwald performed 227,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Greenwald receive payments from pharmaceutical companies?
Yes. Dr. Greenwald received a total of $2,937 from 43 companies across 159 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greenwald's costs compare to other hematology & oncology specialists in Kingston?
Dr. Greenwald's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greenwald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →